Agalsidase Beta and breast feeding
No information is available on the clinical use of agalsidase beta during breastfeeding. Because it is a large protein molecule with a molecular weight of about 100,000, the amount in milk is likely to be very low and absorption is unlikely because it is probably destroyed in the infant's gastrointestinal tract. Six infants who were breastfed for periods up to 12 months by mothers taking the closely related drug agalsidase alfa experienced no adverse effects associated with the drug.
Up to date info
Alternative drugs - Agalsidase Beta and breast feeding
Suggested alternatives on Agalsidase Beta and breast feeding, when available and appropriate.
Breast feeding and drugs